J
Joon Sup Yeom
Researcher at Yonsei University
Publications - 189
Citations - 3647
Joon Sup Yeom is an academic researcher from Yonsei University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 31, co-authored 151 publications receiving 2973 citations. Previous affiliations of Joon Sup Yeom include Gachon University & Sungkyunkwan University.
Papers
More filters
Journal ArticleDOI
Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study
Jae-Hoon Song,Po-Ren Hsueh,Doo Ryeon Chung,Kwan Soo Ko,Cheol-In Kang,Kyong Ran Peck,Joon Sup Yeom,Shin Woo Kim,Hyun-Ha Chang,Yeon Sook Kim,Sook-In Jung,Jun Seong Son,Thomas Man-kit So,M. K. Lalitha,Yonghong Yang,Shao-Guang Huang,Hui Wang,Quan Lu,Celia C. Carlos,Jennifer Perera,Cheng-Hsun Chiu,Jien-Wei Liu,Anan Chongthaleong,Visanu Thamlikitkul,Pham Hung Van,Hyuck Lee,Thomas M. K. So,David Jien-Wei Liu,Dilip Mathai,Jennifer Perera,Tran Van Ngoc +30 more
TL;DR: It is confirmed that MRSA infections in the community have been increasing in Asian countries and data suggest that various MRSA clones have spread between the community and hospitals as well as between countries.
Journal ArticleDOI
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea
Jin Young Ahn,Yujin Sohn,Su Hwan Lee,Yunsuk Cho,Jong Hoon Hyun,Yae Jee Baek,Su Jin Jeong,Jung Ho Kim,Nam Su Ku,Joon Sup Yeom,Juhye Roh,Mi Young Ahn,Bum Sik Chin,Young Sam Kim,Hyukmin Lee,Dongeun Yong,Hyun Ok Kim,Shinyoung Kim,Jun Yong Choi +18 more
TL;DR: To the authors' knowledge, this is the first report of the use of convalescent plasma therapy for COVID-19 in Korea and both patients presented severe pneumonia with acute respiratory distress syndrome and showed a favorable outcome after theUse of convalscent plasma in addition to systemic corticosteroid.
Journal ArticleDOI
Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens.
Jae-Hoon Song,Won Sup Oh,Cheol-In Kang,Doo Ryeon Chung,Kyong Ran Peck,Kwan Soo Ko,Joon Sup Yeom,Choon Kwan Kim,Shin Woo Kim,Hyun-Ha Chang,Yeon Sook Kim,Sook-In Jung,Zhaohui Tong,Qingtao Wang,Shao-Guang Huang,Jien-Wei Liu,M. K. Lalitha,Ban Hock Tan,Pham Hung Van,Celia C. Carlos,Thomas Man-kit So +20 more
TL;DR: A prospective observational study of adult CAP in 14 hospitals in eight Asian countries provides relevant information about pathogen distribution and antimicrobial resistance of major pathogens of CAP as well as clinical outcomes of illness in Asian countries.
Journal ArticleDOI
Pharmacokinetics of Hydroxychloroquine and Its Clinical Implications in Chemoprophylaxis against Malaria Caused by Plasmodium vivax
Hyeong-Seok Lim,Jeong-Soo Im,Joo Youn Cho,Kyun-Seop Bae,Terry A. Klein,Joon Sup Yeom,Tae-Seon Kim,Jae-Seon Choi,In-Jin Jang,Jae-Won Park +9 more
TL;DR: Hydroxychloroquine is an antimalarial drug used as chemoprophylaxis against malaria caused by Plasmodium vivax in the Republic of Korea Army (ROKA), and a significant cause of prophylactic failure among the individuals in ROKA was ascribed to plasma concentrations of HCQ lower than those predicted by the PK model.
Journal ArticleDOI
Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study.
TL;DR: In this large cohort of apparently healthy Korean adults, HBsAg seropositivity was associated with lower risk of developing nonalcoholic fatty liver disease, indicating a possible effect of HBV infection on the pathogenesis of NAFLD development.